Live Breaking News & Updates on David Hudesman

Stay updated with breaking news from David hudesman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The Role of Vedolizumab and Risankizumab in CD

Anita Afzali, MD, David Hudesman, MD, Millie Long, and Miguel Regueiro, MD, discuss Vedolizumab and Risankizumab as treatments for Crohn’s Disease (CD). ....

United States , Miguel Regueiro , David Hudesman , Anita Afzali , Crohns Disease , Risk Stratification , Bio Naïve Population , Tumor Necrosis Factor ,

Efficacy and Safety of Ustekinumab for CD

Efficacy and Safety of Ustekinumab for CD
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

Maia Kayal , David Hudesman ,

Managing Care for IBD Patients Not Responding to Treatment

Experts discuss how to care for Inflammatory Bowel Disease (IBD) patients who are not responding to treatment. ....

Anita Afzali , David Hudesman , Inflammatory Bowel Disease , Crohns Disease , Ulcerative Colitis , Proactive Disease Monitoring ,

Selecting First-Line Treatments for CD

David Hudesman, MD, Miguel Regueiro, MD, and Maia Kayal, MD, offer first line treatment strategies for patients with Crohn’s Disease (CD). ....

Miguel Regueiro , Maia Kayal , David Hudesman , Theni D , Crohns Disease , First Line Agent , Combination Therapy , Risk Stratification ,

Treatment Factors of IBD

Experts discuss treatment options for patients with Inflammatory Bowel Disease (IBD) and clinical factors to consider. ....

Anita Afzali , Maia Kayal , David Hudesman , Miguel Regueiro , Inflammatory Bowel Disease , Crohns Disease , Ulcerative Colitis , Treatment Options , Therapy Impact ,